Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BKNG | ABNB |
|---|---|---|
| Price | $157.18 | $149.80 |
| Change today | ▲ 0.82% | ▲ 0.15% |
| Market cap | $118.10B | $89.70B |
| Return, 3 months | -13.1% | +3.7% |
| Return, year to date | -26.1% | +10.4% |
| Return, 1 year | -28.2% | +21.7% |
| P/E (TTM) | 17.5 | 34.2 |
| P/B | -11.0 | 11.5 |
| P/E percentile vs own 5y | 0th | 67th |
| Dividend yield | 1.02% | – |
| Revenue growth (YoY, latest qtr) | +8.1% | +16.5% |
| Net profit growth (YoY) | +117.9% | +27.1% |
| Gross margin | – | 82.9% |
| Operating margin | 34.5% | 20.8% |
| Net margin | 25.5% | 20.4% |
| Return on equity | – | 34.5% |
| Analyst target vs. price | +51.0% | +27.2% |
| Analyst buy share | 81% | 65% |
| RSI (14) | 22 | 29 |
| 30-day volatility | 33.9% | 31.8% |
| Max drawdown, 1 year | -30.6% | -19.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.